These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 29044967)

  • 1. Comparison of long-term outcomes of 50 and 100 mg rt-PA in the management of acute pulmonary thromboembolism.
    Yilmazel Ucar E; Araz O; Kerget B; Yilmaz N; Akgun M; Saglam L
    Clin Respir J; 2018 Apr; 12(4):1628-1634. PubMed ID: 29044967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of low dose recombinant tissue-type plasminogen activator for the treatment of acute pulmonary thromboembolism: a randomized, multicenter, controlled trial.
    Wang C; Zhai Z; Yang Y; Wu Q; Cheng Z; Liang L; Dai H; Huang K; Lu W; Zhang Z; Cheng X; Shen YH;
    Chest; 2010 Feb; 137(2):254-62. PubMed ID: 19741062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-World Outcomes of Acute Ischemic Stroke Treatment with Intravenous Recombinant Tissue Plasminogen Activator.
    Betts KA; Hurley D; Song J; Sajeev G; Guo J; Du EX; Paschoalin M; Wu EQ
    J Stroke Cerebrovasc Dis; 2017 Sep; 26(9):1996-2003. PubMed ID: 28689999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term results of low-dose tissue plasminogen activator therapy in acute pulmonary embolism.
    Hezer H; Kiliç H; Abuzaina O; Hasanoǧlu HC; Karalezli A
    J Investig Med; 2019 Dec; 67(8):1142-1147. PubMed ID: 31341000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lower dosage of recombinant tissue-type plasminogen activator (rt-PA) in the treatment of acute pulmonary embolism: a systematic review and meta-analysis.
    Zhang Z; Zhai ZG; Liang LR; Liu FF; Yang YH; Wang C
    Thromb Res; 2014 Mar; 133(3):357-63. PubMed ID: 24412030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Catheter-directed thrombolytic intervention is effective for patients with massive and submassive pulmonary embolism.
    Akin H; Al-Jubouri M; Assi Z; Acino R; Sepanski D; Comerota AJ
    Ann Vasc Surg; 2014 Oct; 28(7):1589-94. PubMed ID: 24911801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [An economic evaluation of low dose recombinant human tissue-type plasminogen activator for the treatment of acute pulmonary thromboembolism].
    Wu YQ; Tao LB; Lü C; Hu YH
    Zhonghua Yi Xue Za Zhi; 2010 Jan; 90(2):103-6. PubMed ID: 20356492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chronic effects of 100 mg/2 hours recombinant tissue-type plasminogen activator therapy regimen for patients with acute pulmonary thromboembolism].
    Li ZP; Xu B; Jiang R; Li JL; Jiang X; Sun ML; Jing ZC; Li YP
    Zhonghua Xin Xue Guan Bing Za Zhi; 2013 Mar; 41(3):224-8. PubMed ID: 23879948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute pulmonary thromboembolism: Epidemiology, predictors, and long-term outcome - A single center experience.
    Nagamalesh UM; Prakash VS; Naidu KCK; Sarthak S; Hegde AV; Abhinay T
    Indian Heart J; 2017; 69(2):160-164. PubMed ID: 28460762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cost-benefit study of different thrombolytic strategies in treating 156 patients with symptomatic pulmonary thromboembolism].
    Li XS; Deng XY; Liu HL
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2012 Jun; 24(6):355-6. PubMed ID: 22681664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Study of Intravenous, Low-Dose Recombinant Tissue Plasminogen Activator for Acute Cerebral Infarction: Comparison of Treatment within 3 Hours versus 3-4.5 Hours.
    Deguchi I; Tanahashi N; Takao M
    J Stroke Cerebrovasc Dis; 2018 Apr; 27(4):1033-1040. PubMed ID: 29221968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombolytic therapy with intravenous recombinant tissue plasminogen activator in Japanese older patients with acute ischemic stroke: Fukuoka Stroke Registry.
    Matsuo R; Kamouchi M; Ago T; Hata J; Shono Y; Kuroda J; Wakisaka Y; Sugimori H; Kitazono T;
    Geriatr Gerontol Int; 2014 Oct; 14(4):954-9. PubMed ID: 24320947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized trial of a single bolus dosage regimen of recombinant tissue plasminogen activator in patients with acute pulmonary embolism.
    Levine M; Hirsh J; Weitz J; Cruickshank M; Neemeh J; Turpie AG; Gent M
    Chest; 1990 Dec; 98(6):1473-9. PubMed ID: 2123152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Changes of blood coagulative and fibrinolytic system and function of pulmonary vascular endothelium after therapy in patients with acute pulmonary thromboembolism].
    Pang BS; Wang C; Lu Y; Yang YH; Xing GH; Mao YL; Huang XX; Zhai ZG
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(43):3074-8. PubMed ID: 18261355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombolytic treatment (alteplase; rt-Pa) in acute massive pulmonary embolism and cardiopulmonary arrest.
    Dirican A; Ozkaya S; Atas AE; Ulu EK; Kitapci I; Ece F
    Drug Des Devel Ther; 2014; 8():759-63. PubMed ID: 24959070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pharmacoeconomic assessment of recombinant tissue plasminogen activator therapy for acute ischemic stroke in a tertiary hospital in China.
    Yan X; Hu HT; Liu S; Sun YH; Gao X
    Neurol Res; 2015 Apr; 37(4):352-8. PubMed ID: 25297471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombolytic Therapy by Tissue Plasminogen Activator for Pulmonary Embolism.
    Islam MS
    Adv Exp Med Biol; 2017; 906():67-74. PubMed ID: 27628004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness and safety of bolus administration of alteplase in massive pulmonary embolism.
    Diehl JL; Meyer G; Igual J; Collignon MA; Giselbrecht M; Even P; Sors H
    Am J Cardiol; 1992 Dec; 70(18):1477-80. PubMed ID: 1442621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time of day, outcome, and response to thrombolytic therapy: the National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Trial experience.
    Rhoney DH; Coplin WM; Lin Y; Frankel M; Lyden PD; Levine SR
    J Stroke Cerebrovasc Dis; 2010 Jan; 19(1):40-8. PubMed ID: 20123226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of ultra-high-dose, short-term thrombolysis with rt-PA for acute lower limb ischemia.
    Falkowski A; Poncyljusz W; Samad RA; Mokrzyński S
    Eur J Vasc Endovasc Surg; 2013 Jul; 46(1):118-23. PubMed ID: 23683391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.